AUPQ761100A0 - Lipophilic medicament - Google Patents

Lipophilic medicament

Info

Publication number
AUPQ761100A0
AUPQ761100A0 AUPQ7611A AUPQ761100A AUPQ761100A0 AU PQ761100 A0 AUPQ761100 A0 AU PQ761100A0 AU PQ7611 A AUPQ7611 A AU PQ7611A AU PQ761100 A AUPQ761100 A AU PQ761100A AU PQ761100 A0 AUPQ761100 A0 AU PQ761100A0
Authority
AU
Australia
Prior art keywords
lipophilic medicament
lipophilic
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPQ7611A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AUSTRALIAN RURAL GROUP Ltd
Original Assignee
AUSTRALIAN RURAL GROUP Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AUSTRALIAN RURAL GROUP Ltd filed Critical AUSTRALIAN RURAL GROUP Ltd
Priority to AUPQ7611A priority Critical patent/AUPQ761100A0/en
Publication of AUPQ761100A0 publication Critical patent/AUPQ761100A0/en
Priority to PCT/AU2001/000571 priority patent/WO2001087355A1/en
Priority to AU2001258044A priority patent/AU2001258044A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AUPQ7611A 2000-05-18 2000-05-18 Lipophilic medicament Abandoned AUPQ761100A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPQ7611A AUPQ761100A0 (en) 2000-05-18 2000-05-18 Lipophilic medicament
PCT/AU2001/000571 WO2001087355A1 (en) 2000-05-18 2001-05-18 Lipophilic medicament
AU2001258044A AU2001258044A1 (en) 2000-05-18 2001-05-18 Lipophilic medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ7611A AUPQ761100A0 (en) 2000-05-18 2000-05-18 Lipophilic medicament

Publications (1)

Publication Number Publication Date
AUPQ761100A0 true AUPQ761100A0 (en) 2000-06-08

Family

ID=3821689

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPQ7611A Abandoned AUPQ761100A0 (en) 2000-05-18 2000-05-18 Lipophilic medicament

Country Status (2)

Country Link
AU (1) AUPQ761100A0 (en)
WO (1) WO2001087355A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20030153A1 (en) 2003-04-03 2004-10-04 Exall S R L WATER SOLUBLE FORMULATION CONTAINING UBICHINONE FOR OPHTHALMIC USE.
ATE547404T1 (en) 2003-09-22 2012-03-15 Msd Kk PIPERIDINE DERIVATIVES
NZ562766A (en) 2005-05-30 2011-03-31 Banyu Pharma Co Ltd Piperidine derivatives as histamine-H3 receptor antagonists
JPWO2007018248A1 (en) 2005-08-10 2009-02-19 萬有製薬株式会社 Pyridone compounds
US7875633B2 (en) 2005-08-24 2011-01-25 Banyu Pharmaceutical Co., Ltd. Phenylpyridone derivative
JPWO2007029847A1 (en) 2005-09-07 2009-03-19 萬有製薬株式会社 Bicyclic aromatic substituted pyridone derivatives
JPWO2007049798A1 (en) 2005-10-27 2009-04-30 萬有製薬株式会社 New benzooxathiin derivatives
NZ568292A (en) 2005-11-10 2011-08-26 Msd Kk Spiro[cyclohexane-1,1'-(3'H)-4'-azaisobenzofuran]-4-carboxamide derivatives
EP2072519A4 (en) 2006-09-28 2009-10-21 Banyu Pharma Co Ltd Diaryl ketimine derivative
AU2009229860A1 (en) 2008-03-28 2009-10-01 Msd K.K. Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor
AU2009261248A1 (en) 2008-06-19 2009-12-23 Banyu Pharmaceutical Co., Ltd. Spirodiamine-diarylketoxime derivative
WO2010013595A1 (en) 2008-07-30 2010-02-04 萬有製薬株式会社 (5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative
EP4193989A1 (en) * 2021-12-09 2023-06-14 Atlas Molecular Pharma, S.L. A formulation for an effective oral administration of ciclopirox with no adversal gasterointestinal toxicity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624351B1 (en) * 1987-12-15 1991-11-22 Rhone Poulenc Sante ENZYMATICALLY DEGRADABLE COMPOSITIONS FOR COATING FOOD ADDITIVES FOR RUMINANTS
DE69229881T2 (en) * 1991-10-04 1999-12-09 Yoshitomi Pharmaceutical DELAYED RELEASE TABLET
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Also Published As

Publication number Publication date
WO2001087355A1 (en) 2001-11-22

Similar Documents

Publication Publication Date Title
AU2002218250A1 (en) Medicament dispenser
AU2001288294A1 (en) Anti-hypercholesterolemic drug combination
AU2001269529A1 (en) Medicine comprising dicyanopyridine derivative
AU2001246876A1 (en) Remedies
AU2001246877A1 (en) Remedies
AU2001280138A1 (en) Hard capsule
AU2001240856A1 (en) Capsules
AU2001274548A1 (en) Syringe
AU2002223562A1 (en) Medicament dispenser
AU2001240838A1 (en) Capsules
AU2001290239A1 (en) Medicinal composition
AUPQ761100A0 (en) Lipophilic medicament
AU2002221099A1 (en) Combination drugs
AU2001243515A1 (en) Combination drug therapy
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2001232244A1 (en) Drug comprising combination
AU2002227925A1 (en) Human beta-defensin-3
HUP0000997A3 (en) New medicament combination
AU2001260236A1 (en) Restricted use syringe
AU2001272718A1 (en) Medicaments
AU2001282527A1 (en) Antiparkinsonism drugs
AU2002215902A1 (en) Medicament dispenser
AU2001292578A1 (en) Pharmaceutical compounds
AU2002223437A1 (en) Medicament dispenser
AU2000279374A1 (en) Secure syringe

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 5804401

Country of ref document: AU